|
|
|
l |
Home | l | UK Companies | l | Genomics Topics | l | Species with sequenced Genomes | l | Contact |
l |
|
Loading...
| ||||||||||||||
Recent Publications by AstraZeneca: | ![]() | |
| The significance of ambient-temperature on pharmaceutical and endogenous compound abundance and distribution in tissues sections when analyzed by matrix-assisted laser desorption/ionization mass spectrometry imaging.
RATIONALE: Mass spectrometry imaging has proven to be a complementary... | Medical Mass Spectrometry, Department of Pharmaceutical Biosciences, | Rapid Commun Mass Spectrom. 2012 Mar 15;26(5):494-8. doi:
DOI Direct Link |
| Biomarkers of Collecting Duct Injury in Han-Wistar and Sprague-Dawley Rats Treated with N-Phenylanthranilic Acid.
N-phenylanthranilic acid is a chloride channel blocker that causes renal... | AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, UK. | Toxicol Pathol. 2012 Feb 1.
DOI Direct Link |
| Medicinal chemistry matters - a call for discipline in our discipline.
Medicinal chemistry makes a vital contribution to small molecule drug... | AstraZeneca Pharmaceuticals, Cardiovascular and Gastrointestinal Research, | Drug Discov Today. 2012 Jan 25.
DOI Direct Link |
| Optimisation of DMPK by the Inhaled Route: Challenges and Approaches.
The renewed interest in inhalation delivery over recent years has led to... | Discovery DMPK, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, | Curr Drug Metab. 2012 Feb 2. |
| The subjective well-being under neuroleptic scale - short version (SWN-K) and the SF-36 health survey as quality of life measures in patients with schizophrenia.
PURPOSE: The desired outcome in schizophrenia treatment has evolved from... | AstraZeneca Medical Department, Madrid, Spain. | Patient Prefer Adherence. 2012;6:83-5. Epub 2012 Jan 23.
DOI Direct Link |
AstraZeneca Patents: | ![]() |
| US Patent No. | Title |
| 8012964 | 9-substituted 8-oxoadenine compound |
| 8026396 | Processes for the preparation of optically active intermediates |
| 8030340 | Indazolyl sulphonamide derivatives useful as glucocorticoid modulators |
| 8030500 | Substituted isoindoles for the treatment and/or prevention of A.beta.- related pathologies |
| 8034932 | Chemical process |